Surgery Websites
Hepatobiliary & Pancreatic Surgery »  Meet the Team »  Hepatology »  Mohamed Abdelgadir Adam, M.D.
Mohamed Abdelgadir Adam, M.D.

Mohamed Abdelgadir Adam, M.D.

Assistant Professor of Surgery in Residence

Contact Information

Clinic Appointments:
UCSF Helen Diller Family Comprehensive Cancer Center
1825 Fourth Street, 4th Floor
San Francisco, CA 94158
Tel: 415-502-5577
Fax: 415-502-2236

Academic Office:
University of California, San Francisco
513 Parnassus Avenue, HSW 1601
San Francisco, CA 94143-0790
Tel: 415-514-3891
Fax: 415-476-8694
Open Popup

MD: Faculty of Medicine and Health Sciences, Omdurman Islamic University, Sudan

  • 2018: General Surgery Residency, Duke University Medical Center
  • 2020: Complex General Surgical Oncology Fellowship, University of Pittsburgh Medical Center, Pittsburgh, PA
  • 2010: Postdoctoral Research Fellowship, Duke Institute for Genome Sciences & Policy, Durham, NC
  • 2016: Research Fellowship, Duke Clinical Research Institute, Durham, NC
  • American Board of Surgery, General Surgery
  • Health Services Research
  • Leveraging translational artificial intelligence and machine learning in optimizing staging and management of gastrointestinal cancers.
  • Arabic

Mohamed Abdelgadir Adam is an assistant professor in the Division of Hepatobiliary and Pancreatic Surgery. He is a cancer surgeon who treats gastrointestinal tumors and specializes in the treatment of cancers of the pancreas and bile ducts. Dr. Adam has special expertise in robotic minimally invasive pancreato-biliary surgery, including robotic pancreaticoduodenectomy (Whipple procedure). Additionally, he has experience in regional treatment strategies for metastatic cancers in the liver and the peritoneal cavity, including placement of hepatic infusion pumps for patients with unresectable (colorectal and intrahepatic cholangiocarcinoma) liver disease and cytoreductive surgery with Hyperthermic Intraperitoneal Chemotherapy (HIPEC).

Dr. Adam received his medical degree from the Faculty of Medicine and Health Sciences. He completed general surgery training at Duke University Medical Center in Durham, NC. He continued his training with a two-year fellowship in complex surgical oncology at the University of Pittsburgh Medical Center in Pittsburgh, PA. Dr. Adam also completed two research fellowships at Duke University.

Dr. Adam's research focuses on leveraging translational artificial intelligence and machine learning algorithms to optimize cancer patients' treatment. He is a prolific researcher and has already authored over one hundred publications. He is a member of several professional societies. Dr. Adam already received many academic honors at Duke University and UCSF.

Dr. Adam's research focuses on leveraging translational artificial intelligence and machine learning algorithms to optimize cancer staging and treatment. He is a prolific researcher and has already authored over one hundred publications.

Data provided by UCSF Profiles, powered by CTSI
  1. Adam MA, Paniccia A. ASO Author Reflections: Neoadjuvant Chemotherapy for Pancreatic Adenocarcinoma Lessens the Deleterious Effect of Omission of Adjuvant Chemotherapy. Ann Surg Oncol. 2021 Jul; 28(7):3808-3809. View in PubMed

 

Site Directory
    X